Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability

Nutrition Reviews

Volumn 68, Issue 2, 2010, Pages 99-113

  Laanpere, Margit ^a   Altmäe, Signe ^a,b   Stavreus Evers, Anneli ^c   Nilsson, Torbjörn K ^d   Yngve, Agneta ^e   Salumets, Andres ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Fertility; Folate; Homocysteine; MTHFR; Reproduction

Indexed keywords

5 METHYLTETRAHYDROFOLATEHOMOCYSTEINE METHYLTRANSFERASE; 5 METHYLTETRAHYDROFOLATEHOMOCYSTEINE METHYLTRANSFERASE REDUCTASE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLATE RECEPTOR; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; HOMOCYSTEINE; REDUCED FOLATE CARRIER; SOLUTE CARRIER FAMILY 46 MEMEBER 1; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

AMINO ACID BLOOD LEVEL; CARBON METABOLISM; DNA METHYLATION; DNA SYNTHESIS; EMBRYO DEVELOPMENT; FEMALE FERTILITY; FERTILIZATION IN VITRO; FETAL WELL BEING; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; LIVE BIRTH; MOTHER FETUS RELATIONSHIP; NUCLEOTIDE METABOLISM; OOCYTE MATURATION; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE FLUID; PREGNANCY TERMINATION; REPRODUCTION; REVIEW; BLOOD; DRUG EFFECT; FEMALE; FERTILITY; FETUS DEVELOPMENT; GENETICS; METABOLISM; PREGNANCY; PREGNANCY OUTCOME;

DNA METHYLATION; FEMALE; FERTILITY; FETAL DEVELOPMENT; FOLIC ACID; FOLIC ACID DEFICIENCY; GENETIC VARIATION; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PREGNANCY; PREGNANCY MAINTENANCE; PREGNANCY OUTCOME;

EID: 77950356480     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2009.00266.x     Document Type: Review

References (140)

1. Matherly LH, Goldman DI. Membrane transport of folates. Vitam Horm. 2003;66:403-456.
2. Shayeghi M, Latunde-Dada GO, Oakhill JS, et al. Identification of an intestinal heme transporter. Cell. 2005;122:789-801.
3. Qiu A, Jansen M, Sakaris A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127:917-928.
4. Zhao R,Min SH,Wang Y, Campanella E, LowPS, Goldman ID. A role for the proton-coupled folate transporter (PCFTSLC46A1) in folate receptor-mediated endocytosis. J Biol Chem. 2009;284:4267-4274.
5. Matherly LH, Hou Z, Deng Y. Human reduced folate carrier: Translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev. 2007;26:111-128.
6. Antony AC. Folate receptors. Annu Rev Nutr. 1996;16:501-521.
7. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer. 1994;73:2432-2443.
8. Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA. Cellular localization of the folate receptor: Potential role in drug toxicity and folate homeostasis. Cancer Res. 1992;52:6708-6711.
9. de Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP. Folate intake in Europe: Recommended, actual and desired intake. Eur J Clin Nutr. 1997; 51:643-660.
10. McNulty H, Dowey le RC, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation. 2006;113:74-80.
11. Perry C, Yu S, Chen J, Matharu KS, Stover PJ. Effect of vitamin B6 availability on serine hydroxymethyltransferase in MCF-7 cells. Arch Biochem Biophys. 2007;462:21-27.
12. Kapiszewska M, Kalemba M, Wojciech U, Milewicz T. Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem. 2005;16: 467-478.
13. Oppenheim EW, Adelman C, Liu X, Stover PJ. Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis. J Biol Chem. 2001;276:19855-19861.
14. Favier M, Faure P, Roussel AM, Coudray C, Blache D, Favier A. Zinc deficiency and dietary folate metabolism in pregnant rats. J Trace Elem Electrolytes Health Dis. 1993;7: 19-24.
15. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
16. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274:1698-1702.
17. Brouwer IA, van Dusseldorp M, Thomas CM, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: A randomized trial. Am J Clin Nutr. 1999; 69:99-104.
18. Herbert V. Making sense of laboratory tests of folate status: Folate requirements to sustain normality. Am J Hematol. 1987;26:199-207.
19. James SJ, Cross DR,Miller BJ. Alterations in nucleotide pools in rats fed diets deficient in choline,methionine and/or folic acid. Carcinogenesis. 1992;13:2471-2474.
20. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997;94:3290-3295.
21. Courtemanche C, Elson-Schwab I, Mashiyama ST, Kerry N, Ames BN. Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. J Immunol. 2004;173:3186-3192.
22. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J. 1998;12:1491-1497.
23. Kimura M, Umegaki K, Higuchi M, Thomas P, Fenech M. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr. 2004;134:48-56.
24. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr. 2000;72:998-1003.
25. Zeisel SH. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr. 2009; 89(Suppl):S1488-S1493.
26. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693-1699.
27. Lukusa T, Fryns JP. Human chromosome fragility. Biochim Biophys Acta. 2008;1779:3-16.
28. Wang J, Huff AM, Spence JD, Hegele RA. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clin Genet. 2004;65:483-486.
29. Jeltsch A. Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases. Chembiochem. 2002;3:274-293.
30. Quina AS, Buschbeck M, Di Croce L. Chromatin structure and epigenetics. Biochem Pharmacol. 2006;72:1563-1569.
31. Aagaard-Tillery KM, Grove K, Bishop J, et al. Developmental origins of disease and determinants of chromatin structure: Maternal diet modifies the primate fetal epigenome. J Mol Endocrinol. 2008;41:91-102.
32. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613-621.
33. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J. Folatedeficiency- induced homocysteinaemia in rats: Disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem J. 1994;298(Pt 2):415-419.
34. Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview. J Inherit Metab Dis. 2006; 29:3-20.
35. Vanaerts LA, Blom HJ, Deabreu RA, et al. Prevention of neural tube defects by and toxicity of l-homocysteine in cultured postimplantation rat embryos. Teratology. 1994; 50:348-360.
36. Haggarty P, McCallum H, McBain H, et al. Effect of B vitamins and genetics on success of in-vitro fertilisation: Prospective cohort study. Lancet. 2006;367:1513-1519.
37. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000;15:954-960.
38. Di Simone N, Maggiano N, Caliandro D, et al. Homocysteine induces trophoblast cell death with apoptotic features. Biol Reprod. 2003;69:1129-1134.
39. Ayar A, Celik H, Ozcelik O, Kelestimur H. Homocysteineinduced enhancement of spontaneous contractions of myometrium isolated from pregnant women. Acta Obstet Gynecol Scand. 2003;82:789-793.
40. De La Haba G, Cantoni GL. The enzymatic synthesis of S-adenosyl-L- homocysteine from adenosine and homocysteine. J Biol Chem. 1959;234:603-608.
41. Hoffman DR, Marion DW, Cornatzer WE, Duerre JA. S-adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of l-methionine, l-homocystein, and adenosine. J Biol Chem. 1980;255: 10822-10827.
42. Jiang Y, Sun T, Xiong J, Cao J, Li G, Wang S. Hyperhomocysteinemia- mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim Biophys Sin (Shanghai). 2007;39:657-667.
43. Fell D, Selhub J. Disruption of thymidylate synthesis and glycine-serine interconversion by l-methionine and l-homocystine in Raji cells. Biochim Biophys Acta. 1990; 1033:80-84.
44. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: Implications for vascular disease. Circulation. 2001;103:2717-2723.
45. Edirimanne VE, Woo CW, Siow YL, Pierce GN, Xie JY, O K. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can J Physiol Pharmacol. 2007;85:1236-1247.
46. Outinen PA, Sood SK, Pfeifer SI, et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood. 1999;94:959-967.
47. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991;88:1906-1914.
48. Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 2007;18:716-731.
49. Zhang C, Cai Y, AdachiMT, et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem. 2001;276:35867-35874.
50. Jakubowski H. Homocysteine thiolactone: Metabolic origin and protein homocysteinylation in humans. J Nutr. 2000;130(Suppl):S377-S381
51. Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol. 2008;59(Suppl):155- 167.
52. Kamudhamas A, Pang L, Smith SD, Sadovsky Y, Nelson DM. Homocysteine thiolactone induces apoptosis in cultured human trophoblasts: A mechanism for homocysteinemediated placental dysfunction? Am J Obstet Gynecol. 2004;191:563-571.
53. Colucci M, Cattaneo M, Martinelli I, Semeraro F, Binetti BM, Semeraro N. Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential. J Thromb Haemost. 2008;6:1571-1577.
54. Yasuda S, Hasui S, Yamamoto C, et al. Placental folate transport during pregnancy. Biosci Biotechnol Biochem. 2008;72:2277-2284.
55. Prasad PD, Ramamoorthy S, Moe AJ, Smith CH, Leibach FH, Ganapathy V. Selective expression of the high-affinity isoform of the folate receptor (FR-alpha) in the human placental syncytiotrophoblast and choriocarcinoma cells. Biochim Biophys Acta. 1994;1223:71-75.
56. Piedrahita JA, Oetama B, Bennett GD, et al. Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet. 1999;23:228-232.
57. Barber RC, Shaw GM, Lammer EJ, et al. Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet. 1998;76:310-317.
58. Heil SG, van der Put NM, Trijbels FJ, Gabreels FJ, Blom HJ. Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet. 1999;7:393-396.
59. Scapoli L, Marchesini J, Martinelli M, et al. Study of folate receptor genes in nonsyndromic familial and sporadic cleft lip with or without cleft palate cases. Am J Med Genet A. 2005;132:302-304.
60. Börjel AK, Yngve A, Sjöström M, Nilsson TK. Novelmutations in the 5'-UTR of the FOLR1 gene. Clin Chem Lab Med. 2006;44:161-167.
61. Böttiger AK, Hagnelius NO, Nilsson TK. Mutations in exons 2 and 3 of the FOLR1 gene in demented and non-demented elderly subjects. Int J Mol Med. 2007;20:653-662.
62. Nilsson TK, Borjel AK. Novel insertion and deletion mutations in the 5'-UTR of the folate receptor-alpha gene: An additional contributor to hyperhomocysteinemia? Clin Biochem. 2004;37:224-229.
63. Baker H, Frank O, Deangelis B, Feingold S, Kaminetzky HA. Role of placenta in maternal-fetal vitamin transfer in humans. Am J Obstet Gynecol. 1981;141:792-796.
64. Bisseling TM, Steegers EA, van den Heuvel JJ, et al. Placental folate transport and binding are not impaired in pregnancies complicated by fetal growth restriction. Placenta. 2004;25:588-593.
65. Henderson GI, Perez T, Schenker S, Mackins J, Antony AC. Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: Evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med. 1995;126:184-203.
66. Landon MJ, Eyre DH, Hytten FE. Transfer of folate to the fetus. Br J Obstet Gynaecol. 1975;82:12-19.
67. Willmott M, Bartosik DB, Romanoff EB. The effect of folic acid on superovulation in the immature rat. J Endocrinol. 1968;41:439-445.
68. Mohanty D, Das KC. Effect of folate deficiency on the reproductive organs of female rhesus monkeys: A cytomorphological and cytokinetic study. J Nutr. 1982;112:1565-1576.
69. Mooij PN,Wouters MG, Thomas CM, DoesburgWH, Eskes TK. Disturbed reproductive performance in extreme folic acid deficient golden hamsters. Eur J Obstet Gynecol Reprod Biol. 1992;43:71-75.
70. Xiao S, Hansen DK, Horsley ET, et al. Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues. Birth Defects Res A Clin Mol Teratol. 2005;73:6-28.
71. Wills L. Treatment of "pernicious anaemia of pregnancy"and "tropical anaemia"with special reference to yeast extract as a curative agent. Br Med J. 1931;1:1059-1064.
72. Council MR. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study.MRC Vitamin Study Research Group. Lancet. 1991;338:131-137.
73. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
74. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: Time trend analysis in Quebec, Canada. BMJ. 2009;338:b1673.
75. Tolarova M, Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology. 1995;51:71-78.
76. Johnson CY, Little J. Folate intake, markers of folate status and oral clefts: Is the evidence converging? Int J Epidemiol. 2008;37:1041-1058.
77. Martinez-Frias ML, Perez B, Desviat LR, et al. Maternal polymorphisms 677C-T and 1298A-C of MTHFR, and 66A-G MTRR genes: Is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome? Am J Med Genet A. 2006;140:987-997.
78. Hibbard BM, Hibbard ED, Hwa TS, Tan P. Abruptio placentae and defective folate metabolism in Singapore women. J Obstet Gynaecol Br Commonw. 1969;76:1003-1007.
79. Mignini LE, Latthe PM, Villar J, Kilby MD, Carroli G, Khan KS. Mapping the theories of preeclampsia: The role of homocysteine. Obstet Gynecol. 2005;105:411-425.
80. George L, Mills JL, Johansson AL, et al. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288:1867-1873.
81. Lindblad B, Zaman S, Malik A, et al. Folate, vitamin B12, and homocysteine levels in South Asian women with growthretarded fetuses. Acta Obstet Gynecol Scand. 2005;84: 1055-1061.
82. Steegers-Theunissen RP, Steegers EA, Thomas CM, et al. Study on the presence of homocysteine in ovarian follicular fluid. Fertil Steril. 1993;60:1006-1010.
83. Brouwer IA, van Dusseldorp M, West CE, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr. 1999;129:1135-1139.
84. O'Keefe CA, Bailey LB, Thomas EA, et al. Controlled dietary folate affects folate status in nonpregnant women. J Nutr. 1995;125:2717-2725.
85. Riddell LJ, Chisholm A, Williams S, Mann JI. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr. 2000;71:1448-1454.
86. Boxmeer JC, Brouns RM, Lindemans J, et al. Preconception folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertil Steril. 2008;89:1766-1770.
87. Szymanski W, Kazdepka-Zieminska A. [Effect of homocysteine concentration in follicular fluid on a degree of oocyte maturity]. Ginekol Pol. 2003;74:1392-1396.
88. Ebisch IM, Peters WH, Thomas CM, Wetzels AM, Peer PG, Steegers-Theunissen RP. Homocysteine, glutathione and related thiols affect fertility parameters in the (sub)fertile couple. Hum Reprod. 2006;21:1725-1733.
89. Berker B, Kaya C, Aytac R, Satiroglu H. Homocysteine concentrations in follicular fluid are associated with poor oocyte and embryo qualities in polycystic ovary syndrome patients undergoing assisted reproduction. Hum Reprod. 2009;24: 2293-2302.
90. Jerzak M, Putowski L, Baranowski W. [Homocysteine level in ovarian follicular fluid or serum as a predictor of successful fertilization]. Ginekol Pol. 2003;74:949-952.
91. Bedaiwy MA, Falcone T, Mohamed MS, et al. Differential growth of human embryos in vitro: Role of reactive oxygen species. Fertil Steril. 2004;82:593-600.
92. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
93. Yamada K, Chen Z, Rozen R, Matthews RG. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA. 2001;98:14853-14858.
94. Böttiger AK, Hurtig-Wennlöf A, Sjöström M, Yngve A, Nilsson TK. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C
95. van der Put NM, Gabreels F, Stevens EM, et al. A second commonmutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044-1051.
96. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002;99:5606-5611.
97. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev. 2000;9:849-853.
98. Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis. 1998;19:1163-1171.
99. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995;56:142-150.
100. Bagley PJ, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA. 1998;95:13217-13220.
101. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169-172.
102. Narayanan S, McConnell J, Little J, et al. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev. 2004;13:1436-1443.
103. Ulvik A, Ueland PM, Fredriksen A, et al. Functional inference of the methylenetetrahydrofolate reductase 677C
104. Thaler CJ, Budiman H, Ruebsamen H, Nagel D, Lohse P. Effects of the common 677C
105. Hecht S, Pavlik R, Lohse P, Noss U, Friese K, Thaler CJ. Common 677C -
106. Rosen MP, Shen S, McCulloch CE, Rinaudo PF, Cedars MI, Dobson AT. Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity. Fertil Steril. 2007;88:632-638.
107. Azem F, Many A, Ben Ami I, et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19:368-370.
108. Qublan HS, Eid SS, Ababneh HA, et al. Acquired and inherited thrombophilia: Implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006;21:2694-2698.
109. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol. 2006;56:230-236.
110. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online. 2006;12:322-327.
111. Martinelli I, Taioli E, Ragni G, et al. Embryo implantation after assisted reproductive procedures and maternal thrombophilia. Haematologica. 2003;88:789-793.
112. Dobson AT, Davis RM, Rosen MP, et al. Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF. Hum Reprod. 2007;22:450-456.
113. Altmäe S, Stavreus-Evers A, Ruiz JR, et al. Variations in folate pathway genes are associated with unexplained female infertility. Fertil Steril. 2009;March 24 (epub ahead of print).
114. Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S, Reyes-Engel A. Genetic selection and folate intake during pregnancy. Lancet. 1998;352:1120-1121.
115. Rosenberg N, Murata M, Ikeda Y, et al. The frequent 5,10- methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet. 2002;70:758-762.
116. Gueant-Rodriguez RM, Gueant JL, Debard R, et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: A comparative study in Mexican,West African, and European populations. Am J Clin Nutr. 2006;83:701-707.
117. Reyes-Engel A, Munoz E, Gaitan MJ, et al. Implications on human fertility of the 677C -
118. Zetterberg H, Regland B, Palmér M, et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet. 2002;10:113-118
119. Bae J, Shin SJ, Cha SH, Choi DH, Lee S, Kim NK. Prevalent genotypes of methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in spontaneously aborted embryos. Fertil Steril. 2007;87:351-355.
120. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am J Hum Genet. 2000;67:986-990.
121. Callejon G, Mayor-Olea A, Jimenez AJ, et al. Genotypes of the C677T and A1298C polymorphisms of the MTHFR gene as a cause of human spontaneous embryo loss. Hum Reprod. 2007;22:3249-3254.
122. Ogino S, Wilson RB. Genotype and haplotype distributions of MTHFR677C
123. Beaudin AE, Stover PJ. Folate-mediated one-carbon metabolism and neural tube defects: Balancing genome synthesis and gene expression. Birth Defects Res C Embryo Today. 2007;81:183-203.
124. Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH. Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am J Clin Nutr. 2006;83:708-713.
125. Devlin AM, Ling EH, Peerson JM, et al. Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet. 2000;9:2837-2844.
126. Fodinger M, Dierkes J, Skoupy S, et al. Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. J Am Soc Nephrol. 2003;14:1314-1319.
127. Halsted CH, Wong DH, Peerson JM, et al. Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: The Hordaland Homocysteine Study. Am J Clin Nutr. 2007;86:514-521.
128. Brattström L,Wilcken DE, Ohrvik J, Brudin L. Commonmethylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation. 1998;98:2520-2526.
129. Chango A, Emery-Fillon N, de Courcy GP, et al. A polymorphism (80G-
130. Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat. 2007;28:856-865.
131. Gudnason V, Stansbie D, Scott J, Bowron A, Nicaud V, Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations. EARS group. Atherosclerosis. 1998;136:347-354.
132. Silaste ML, Rantala M, Sampi M, Alfthan G, Aro A, Kesäniemi YA. Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr. 2001;131:2643-2647.
133. Gaughan DJ, Kluijtmans LA, Barbaux S, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157:451-456.
134. Brilakis ES, Berger PB, Ballman KV, Rozen R. Methylenetetrahydrofolate reductase (MTHFR) 677C
135. Whetstine JR, Gifford AJ,Witt T, et al. Single nucleotide polymorphisms in the human reduced folate carrier: Characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res. 2001;7:3416-3422.
136. Dufficy L, Naumovski N, Ng X, et al. G80A reduced folate carrier SNP influences the absorption and cellular translocation of dietary folate and its association with blood pressure in an elderly population. Life Sci. 2006;79:957-966.
137. Kawakami K, Salonga D, Park JM, et al. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin Cancer Res. 2001;7:4096-4101.
138. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res. 2002;62:3361-3364.
139. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW. Thymidylate synthase: A novel genetic determinant of plasma homocysteine and folate levels. Hum Genet. 2002;111:299-302.
140. Brown KS, Kluijtmans LA, Young IS, et al. The thymidylate synthase tandem repeat polymorphism is not associated with homocysteine concentrations in healthy young subjects. Hum Genet. 2004;114:182-185.